MedPath
FDA Approval

Hydrocodone Bitartrate and Acetaminophen

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
KVK-Tech, Inc.
DUNS: 173360061
Effective Date
January 12, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Hydrocodone(5 mg in 1 1)
Acetaminophen(300 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

ABHAI LLC

079385868

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

KVK-Tech, Inc.

KVK-Tech, Inc.

ABHAI LLC

173360061

Products6

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydrocodone Bitartrate and Acetaminophen

Product Details

NDC Product Code
10702-192
Application Number
ANDA209036
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 12, 2024
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
STARCH, PREGELATINIZED CORNInactive
Code: O8232NY3SJClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
Code: NO70W886KKClass: ACTIBQuantity: 5 mg in 1 1
Code: 362O9ITL9DClass: ACTIBQuantity: 300 mg in 1 1

Hydrocodone Bitartrate and Acetaminophen

Product Details

NDC Product Code
10702-190
Application Number
ANDA209037
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 12, 2024
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
STARCH, PREGELATINIZED CORNInactive
Code: O8232NY3SJClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
Code: NO70W886KKClass: ACTIBQuantity: 7.5 mg in 1 1
Code: 362O9ITL9DClass: ACTIBQuantity: 325 mg in 1 1
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT

Hydrocodone Bitartrate and Acetaminophen

Product Details

NDC Product Code
10702-194
Application Number
ANDA209036
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 12, 2024
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
STARCH, PREGELATINIZED CORNInactive
Code: O8232NY3SJClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
Code: NO70W886KKClass: ACTIBQuantity: 10 mg in 1 1
Code: 362O9ITL9DClass: ACTIBQuantity: 300 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT

Hydrocodone Bitartrate and Acetaminophen

Product Details

NDC Product Code
10702-193
Application Number
ANDA209036
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 12, 2024
Code: NO70W886KKClass: ACTIBQuantity: 7.5 mg in 1 1
Code: 362O9ITL9DClass: ACTIBQuantity: 300 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
STARCH, PREGELATINIZED CORNInactive
Code: O8232NY3SJClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT

Hydrocodone Bitartrate and Acetaminophen

Product Details

NDC Product Code
10702-191
Application Number
ANDA209037
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 12, 2024
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
STARCH, PREGELATINIZED CORNInactive
Code: O8232NY3SJClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
Code: NO70W886KKClass: ACTIBQuantity: 10 mg in 1 1
Code: 362O9ITL9DClass: ACTIBQuantity: 325 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

Hydrocodone Bitartrate and Acetaminophen

Product Details

NDC Product Code
10702-189
Application Number
ANDA209037
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 12, 2024
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
STARCH, PREGELATINIZED CORNInactive
Code: O8232NY3SJClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
Code: 362O9ITL9DClass: ACTIBQuantity: 325 mg in 1 1
Code: NO70W886KKClass: ACTIBQuantity: 5 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath